Correlation study of multiple inflammatory indices and vertebral compression fracture: A cross-sectional study

2024-9-1

Employing user-centered design and education sciences to inform training of diabetes survival skills

2024-9-1

Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients

2024-9-1

Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone

2024-9-1

Letter to the Editor in response to the article “Semaglutide and post kidney transplantation in patients with diabetes”

2024-9-1

Assessment of insulin dose changes in pediatric patients with type 1 diabetes mellitus starting on continuous subcutaneous insulin infusion

2024-9-1

Testosterone deficiency and chronic kidney disease

2024-8-14

Advances in nucleic acid delivery strategies for diabetic wound therapy

2024-8-1

Impact of high-dose cholecalciferol (vitamin D3) and inulin prebiotic on intestinal and airway microbiota in adults with cystic fibrosis: A 2 × 2 randomized, placebo-controlled, double-blind pilot study

2024-7-24

Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review

2024-7-14

Cross-section of thyroidology and nephrology: Literature review and key points for clinicians

2024-7-7

Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]

2024-7-1

Family planning preferences in transgender youth in an urban multi-disciplinary gender clinic

2024-6-1

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience

2024-6-1

Telemedicine care coordination and visit frequency in pediatric patients with type 1 diabetes in Oregon

2024-6-1

Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)

2024-6-1

Management of chronic kidney disease: The current novel and forgotten therapies

2024-6-1

Insulin sensitivity, body composition and bone mineral density after testosterone treatment in transgender youth with and without prior GnRH agonist therapy

2024-6-1

Anti-inflammatory benefits of semaglutide: State of the art

2024-6-1

Effects of Lacticaseibacillus rhamnosus HA-114 probiotic supplementation on circulating IGFBP-2 levels during a calorie-restricted diet in overweight humans

2024-6-1

Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery

2024-5-31

Association between protein arginine N-methyltransferase 1 polymorphism and overt diabetic nephropathy: Role of asymmetric dimethylarginine in vascular tone

2024-5-11

Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or Post-Transplant diabetes

2024-4-6

Changes in blood lipids following initiation of gender affirming hormone therapy: A systematic review and meta-analysis

2024-4-1

Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment

2024-4-1

Bone health and fracture prevention after kidney transplantation

2024-4-1

The association of Gender-Affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults

2024-4-1

Impact of sex used for assignment of reference intervals in a population of patients taking gender-affirming hormones

2024-4-1

Development and acceptability of a culturally competent skills and knowledge assessment tool for patients with diabetes mellitus

2024-4-1

High levels of blood glycemic indicators are associated with chronic kidney disease prevalence in non-diabetic adults: Cross-sectional data from the national health and nutrition examination survey 2005–2016

2024-4-1

Olfactory function in diabetes mellitus

2024-3-30

COVID-19 impacts and inequities among underserved communities with diabetes

2024-3-19

Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules

2024-3-1

Corrigendum to “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals” [J. JCTE 2 (2015) 55–60]

2024-3-1

SGLT2 inhibitors: Beyond glycemic control

2024-3-1

Patient and caregiver perspectives of fluid discharge protocols following pituitary surgery

2024-3-1

Quality of life, daily functioning, and symptoms in hypothyroid patients on thyroid replacement therapy: A Dutch survey

2024-2-1

GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review

2024-2-1

Acceptability of HPV self-collection: A qualitative study of Black women living with type II diabetes and social vulnerability

2024-2-1

The changing landscape of treatment for cystic fibrosis related diabetes

2024-2-1

Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules

2023-12-2

Peripheral sensory neuropathy is associated with circulating angiopoietins in type 2 diabetes patients in Ghana

2023-12-1

Novel interactive text-messaging curriculum for endocrinology board review

2023-12-1

Utilizing a quality of life tool to examine the presence of fatigue in subjects with diabetes mellitus

2023-12-1

The relationship between diabetic ketoacidosis and suicidal or self-injurious behaviour: A systematic review

2023-9-29

Prospective effects of cholecalciferol supplementation on irisin levels in sedentary postmenopausal women: A pilot study

2023-9-15

Reproducibility of in-home CFRD screening using continuous glucose monitoring and mixed meal tolerance test

2023-9-1

Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity

2023-8-17

Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease

2023-7-26

Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes

2023-6-24